Lobar evenness of deposition/retention in rat lungs of inhaled silver nanoparticles: an approach for reducing animal use while maximizing endpoints.


Journal

Particle and fibre toxicology
ISSN: 1743-8977
Titre abrégé: Part Fibre Toxicol
Pays: England
ID NLM: 101236354

Informations de publication

Date de publication:
07 01 2019
Historique:
received: 24 07 2018
accepted: 19 12 2018
entrez: 9 1 2019
pubmed: 9 1 2019
medline: 2 2 2019
Statut: epublish

Résumé

Information on particle deposition, retention and clearance are important for the evaluation of the risk of inhaled nanomaterials to human health. Recent revised OECD inhalation toxicity test guidelines require to evaluate the lung burden of nanomaterials after rodent subacute and subchronic inhalation exposure (OECD 412, OECD 413). These revised test guidelines require additional post-exposure observation (PEO) periods that include lung burden measurements that can inform on lung clearance behavior and translocation. The latter being particularly relevant when the testing chemical is a solid poorly soluble nanomaterial. Therefore, in the spirit of 3 R's, we investigated whether measurement of retained lung burden of inhaled nanoparticles (NPs) in individual lung lobes is sufficient to determine retained lung burden in the total lung. If it is possible to use only one lobe, it will reduce animal use and maximize the number of endpoints evaluated. To achieve these goals, rats were exposed nose-only for 1 or 5 days (6 h/day) to an aerosol of 20 nm well-dispersed silver nanoparticles (AgNPs), which is the desired particle diameter resulting in maximum deposition in the pulmonary region when inhaled as singlets. After exposure, the five lung lobes were separated and silver concentration was measured using inductively coupled plasma-mass spectrophotometer (ICP-MS). The results showed that the retention of deposited silver nanoparticle in the different lung lobes did not show any statistically significant difference among lung lobes in terms of silver mass per gram lung lobe. This novel finding of evenness of retention/deposition of inhaled 20 nm NPs in rats for all five lobes in terms of mass per unit tissue weight contrasts with earlier studies reporting greater apical lobe deposition of inhaled micro-particles in rodents. The difference is most likely due to preferred and efficient deposition of inhaled NPs by diffusion vs. additional deposition by sedimentation and impaction for micron-sized particles. AgNPs following acute inhalation by rats are evenly retained in each lung lobe in terms of mass per unit lung tissue weight. Accordingly, we suggest sampling any of the rat lung lobes for lung burden analysis can be used to determine deposited or retained total lung burden after short-term inhalation of NPs and using the other lobes for collecting and analyzing bronchoalveolar lavage fluid (BALF) and for histopathological analysis. Therefore, by combining lung burden measurement, histopathological tissue preparation, and BALF assay in the same rat will reduce the number of animals used and maximize the number of endpoints measured.

Sections du résumé

BACKGROUND
Information on particle deposition, retention and clearance are important for the evaluation of the risk of inhaled nanomaterials to human health. Recent revised OECD inhalation toxicity test guidelines require to evaluate the lung burden of nanomaterials after rodent subacute and subchronic inhalation exposure (OECD 412, OECD 413). These revised test guidelines require additional post-exposure observation (PEO) periods that include lung burden measurements that can inform on lung clearance behavior and translocation. The latter being particularly relevant when the testing chemical is a solid poorly soluble nanomaterial. Therefore, in the spirit of 3 R's, we investigated whether measurement of retained lung burden of inhaled nanoparticles (NPs) in individual lung lobes is sufficient to determine retained lung burden in the total lung. If it is possible to use only one lobe, it will reduce animal use and maximize the number of endpoints evaluated.
RESULTS
To achieve these goals, rats were exposed nose-only for 1 or 5 days (6 h/day) to an aerosol of 20 nm well-dispersed silver nanoparticles (AgNPs), which is the desired particle diameter resulting in maximum deposition in the pulmonary region when inhaled as singlets. After exposure, the five lung lobes were separated and silver concentration was measured using inductively coupled plasma-mass spectrophotometer (ICP-MS). The results showed that the retention of deposited silver nanoparticle in the different lung lobes did not show any statistically significant difference among lung lobes in terms of silver mass per gram lung lobe. This novel finding of evenness of retention/deposition of inhaled 20 nm NPs in rats for all five lobes in terms of mass per unit tissue weight contrasts with earlier studies reporting greater apical lobe deposition of inhaled micro-particles in rodents. The difference is most likely due to preferred and efficient deposition of inhaled NPs by diffusion vs. additional deposition by sedimentation and impaction for micron-sized particles.
CONCLUSION
AgNPs following acute inhalation by rats are evenly retained in each lung lobe in terms of mass per unit lung tissue weight. Accordingly, we suggest sampling any of the rat lung lobes for lung burden analysis can be used to determine deposited or retained total lung burden after short-term inhalation of NPs and using the other lobes for collecting and analyzing bronchoalveolar lavage fluid (BALF) and for histopathological analysis. Therefore, by combining lung burden measurement, histopathological tissue preparation, and BALF assay in the same rat will reduce the number of animals used and maximize the number of endpoints measured.

Identifiants

pubmed: 30616672
doi: 10.1186/s12989-018-0286-9
pii: 10.1186/s12989-018-0286-9
pmc: PMC6322301
doi:

Substances chimiques

Biomarkers 0
Silver 3M4G523W1G

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2

Subventions

Organisme : Korea Evaluation Institute of Industrial Technology
ID : 10052901
Pays : International
Organisme : NIEHS NIH HHS
ID : P30 ES007033
Pays : United States
Organisme : U.S. Environmental Protection Agency
ID : RD83573801
Pays : International
Organisme : NIEHS NIH HHS
ID : U19 ES019545
Pays : United States

Références

Inhal Toxicol. 2007 Jul;19(9):745-51
pubmed: 17613082
Fundam Appl Toxicol. 1995 Nov;28(1):41-50
pubmed: 8566482
Environ Sci Technol. 2010 Mar 15;44(6):2169-75
pubmed: 20175529
ACS Nano. 2010 Nov 23;4(11):6903-13
pubmed: 20968290
Toxicol Sci. 2003 Jan;71(1):104-11
pubmed: 12520080
Environ Health Perspect. 1984 Apr;55:369-90
pubmed: 6376108
Ann ICRP. 1994;24(1-3):1-482
pubmed: 7726471
Fundam Appl Toxicol. 1988 Apr;10(3):369-84
pubmed: 3286345
Am Ind Hyg Assoc J. 1978 Dec;39(12):1009-18
pubmed: 742592
Physiol Rep. 2014 Jul 04;2(7):
pubmed: 24997068
Chem Asian J. 2010 Feb 1;5(2):285-93
pubmed: 20063340
Int J Toxicol. 2016 Jan-Feb;35(1):47-51
pubmed: 26634628
Nanotoxicology. 2013 Mar;7(2):169-80
pubmed: 22264098
Part Fibre Toxicol. 2015 Apr 26;12:10
pubmed: 25927223
J Appl Toxicol. 2007 Mar-Apr;27(2):160-7
pubmed: 17265416
Toxicol Sci. 2009 Apr;108(2):452-61
pubmed: 19033393
Inhaled Part. 1975 Sep;4 Pt 1:3-21
pubmed: 1236165
Environ Res. 1976 Feb;11(1):13-33
pubmed: 1253768
J Appl Physiol (1985). 2015 Jun 1;118(11):1375-85
pubmed: 25882387
Am J Physiol Lung Cell Mol Physiol. 2016 Dec 1;311(6):L1082-L1089
pubmed: 27760763
Part Fibre Toxicol. 2015 Apr 28;12:11
pubmed: 25927337

Auteurs

Jung Duck Park (JD)

Deparment of Preventive Medicine College of Medicine, Chung-Ang University, Seoul, South Korea.

Jin Kwon Kim (JK)

Department of Nanofusion Technology, Hoseo University, Asan, South Korea.

Mi Seong Jo (MS)

Department of Nanofusion Technology, Hoseo University, Asan, South Korea.

Young Hun Kim (YH)

HCTm CO.,LTD, Seoicheon-ro 578 beon-gil, Majang-myeon, Icheon, 17383, South Korea.

Ki Soo Jeon (KS)

HCTm CO.,LTD, Seoicheon-ro 578 beon-gil, Majang-myeon, Icheon, 17383, South Korea.

Ji Hyun Lee (JH)

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, USA.

Elaine M Faustman (EM)

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, USA.

Hong Ku Lee (HK)

Department of Mechanical Engineering, Hanyang University, Ansan, South Korea.

Kangho Ahn (K)

Department of Mechanical Engineering, Hanyang University, Ansan, South Korea.

Mary Gulumian (M)

National Institute for Occupational Health, University of the Witwatersrand, Johannesburg, South Africa.
Haematology and Molecular Medicine, University of the Witwatersrand, Johannesburg, South Africa.

Günter Oberdörster (G)

Department of Environmental Medicine, University of Rochester, Rochester, NY, USA.

Il Je Yu (IJ)

HCTm CO.,LTD, Seoicheon-ro 578 beon-gil, Majang-myeon, Icheon, 17383, South Korea. u1670916@chollian.net.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH